Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer

Chest

Volumn 126, Issue 2, 2004, Pages 342-346

  Tamura, Masaya ^a   Oda, Makoto ^a   Tsunezuka, Yoshio ^a   Matsumoto, Isao ^a   Kawakami, Kazuyuki ^a   Ohta, Yasuhiko ^b   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Lymph node; Metastasis; Non small cell lung cancer; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN C;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; TREATMENT PLANNING;

EID: 4143102533     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2.342     Document Type: Article

References (11)

1. Thonos S, Ritva J, Pekka K, et al. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 23:403-408
2. Kajita T, Ohta Y, Kimura K, et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 2001; 20:255-260
3. Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2000; 119:804-813
4. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990; 65:2503-2506
5. Izbicki J, Thetter O, Karg O, et al. Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma: a prospective study. J Thorac Cardiovasc Surg 1992; 104:413-420
6. Gdeedo A, Van Schil P, Corthouts B, et al. Comparison of imaging TNM and pathological TNM in staging bronchogenic carcinoma. Eur J Cardiothorac Surg 1997; 12:224-227
7. Daly BDT, Mueller JD, Faling JL, et al. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 1993; 105:904-911
8. Carlens E. Mediastinotomy: a method for inspection and tissue biopsy in the superior mediastinum. Dis Chest 1959; 36:343-347
9. McNeil TM, Chamberlain JM. Diagnostic anterior mediastinotomy. Ann Thorac Surg 1966; 2:532-539
10. Kernstine KH, McLaughlin KA, Menda RY, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer? Ann Thorac Surg 2002; 73:394-402
11. Hans CS, Markus H, Florin A, et al. Non-small cell lung cancer: nodal staging with FDG-PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-446